NMN for Parkinson's Disease: What the Evidence Actually Shows
What is Parkinson's Disease?
Parkinson's disease is a progressive neurodegenerative disorder marked by tremor, rigidity, bradykinesia and postural instability, caused by loss of dopaminergic neurons.
NMN relevance: the published evidence
Small trials of NR (a related NAD+ precursor) in Parkinson's disease have explored brain NAD+ levels and motor scores with modest, mixed results. NMN itself has no completed Parkinson's RCT. Levodopa and other dopaminergic therapies remain standard of care.
Questions to ask before supplementing
No dose validated for Parkinson's disease.
Contraindications and red flags
Coordinate with your neurologist before starting any supplement.
Bottom line for Malaysian patients
NMN is not registered with NPRA as a treatment for any specific condition; it is sold as a general health supplement. If you have parkinson's disease, use this page as a question list for a registered medical practitioner before adding NMN to existing therapy. Read our safety guide for full red-flag context.
Related conditions
- Alzheimer's Disease - Alzheimer's disease is the most common cause of dementia, marked by progressive memory loss, cogniti...
- Age-Related Cognitive Decline - Age-related cognitive decline is the gradual slowing of processing speed, memory and executive funct...
- Biological Aging - Biological aging refers to the gradual decline in cellular and organ function that accompanies chron...
- Mild Cognitive Impairment - Mild cognitive impairment is measurable cognitive decline beyond normal ageing but not severe enough...